Type:

Julianne Ponan has joined the Anaphylaxis Campaign as an Ambassador 4th February 2021

Julianne will work with us to educate, inform and campaign as a high profile entrepreneur who lives with anaphylaxis. Julianne Ponan (31) didn’t start out wanting to be an entrepreneur. She began her career in finance and took her first

Read more
Julianne Ponan has joined the Anaphylaxis Campaign as an Ambassador 4th February 2021

As an ambassador Julianne will work with us to educate, inform and campaign as a high profile entrepreneur who has lived with anaphylaxis since childhood. Julianne Ponan was a toddler when she had her first anaphylactic attack. At nursery after

Read more
Psychological Service Needs for Food Allergy 3rd February 2021

Please take part in the international survey on Psychological Service Needs for Food Allergy headed by Dr Rebecca Knibb at Aston University in collaboration Dr Chrissie Jones, Dr Helen Brough, Dr Linda Herbert, Mary Jane Marchisotto, Centres in the UK,

Read more
Response to Editorial in the BMJ (18 January 2021) 22nd January 2021

We really welcome the Editorial in the BMJ (18th January 2021)-  “Vaccinating against Covid 19 in People who report Allergies.” Click here to read the editorial The Campaign has had an unprecedented number of calls to our helpline from allergic

Read more
Statement regarding death of Ellen Raffell 20th January 2021

We are saddened to learn of the tragic death of Ellen Raffell, aged 16, who sadly died on 31st October 2019. We would like to offer our deepest sympathies to her family at this difficult time. Following the inquest on

Read more
Does your child have peanut allergy? 8th January 2021

Acaster Lloyd Consulting are looking for participants to take part in a research study about caregivers’ and children’s Experiences of taking an oral peanut protein powder (immunotherapy) treatment or 2. Their thoughts about how an oral peanut protein powder (immunotherapy)

Read more
European Commission approves first treatment for peanut allergy 7th January 2021

Aimmune Therapeutics’ PALFORZIA® has been approved by the European Commission as a treatment for peanut allergy. The European Commission (EC) has approved PALFORZIA®  for the treatment of peanut allergy, making it the first treatment for the condition. Produced by Aimmune

Read more
Allergy Therapeutics and Imperial College London start Peanut Allergy Study 6th January 2021

Allergy Therapeutics PLC – Sussex-based biotechnology firm focused on allergy vaccines – Initiates peanut allergy biomarker study with Imperial College London to confirm potential of novel peanut vaccine candidate. The study aims to evaluate the novel virus like particle based

Read more
Entrepreneur and allergy advocate Julianne Ponan is named Anaphylaxis Campaign’s newest ambassador 16th December 2020

The Anaphylaxis Campaign, the only UK-wide charity operating solely for the growing numbers of people at risk from severe allergic reactions, has welcomed a new Ambassador to help raise awareness and create a safer environment for those with allergies. Julianne Ponan,

Read more